Time, location and function of hypoxia-inducible factors are critical to therapeutic tumour response
Citation:
Marignol, L. and Pugh, C.W., Time, location and function of hypoxia-inducible factors are critical to therapeutic tumour response, BMJ Oncology, 3, 1, 2024Download Item:
Abstract:
Multiple lines of evidence confirm isoforms the strong association between the presence of hypoxia in solid tumours and poorer outcomes ihn patients with cancer resulting from both more aggressive tumour cell behaviour and impaired responses to therapy.1 2 With well over 12 000 articles published in the past 5 years alone (source, PubMed), the importance of hypoxia in cancer is indisputable. The impact of hypoxia on cancer cell biology takes multiple forms, but the regulation of the hypoxia-inducible factor (HIF), sits at its core. The review written by Ortmann3 provides an extensive overview of the regulation, function and therapeutic potential of these key dimeric protein complexes. The clarification that several isoforms of HIF exist, classified as 1, 2 or 3, and the fact that they operate in a chromatin environment that is also influenced by oxygenation immediately highlights te complexity in the molecular adaptation of cells, including cancer cells, to modifications in oxygen availability.
Author's Homepage:
http://people.tcd.ie/marignl
Author: Marignol, Laure
Type of material:
Journal ArticleCollections
Series/Report no:
BMJ Oncology3
1
Availability:
Full text availableSubject:
isoforms, data, presence of hypoxiaDOI:
http://dx.doi.org/10.1136/bmjonc-2023-000290Metadata
Show full item recordThe following license files are associated with this item: